These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10634528)

  • 1. The dual-isotope ProstaScint imaging procedure: clinical experience and staging results in 145 patients.
    Quintana JC; Blend MJ
    Clin Nucl Med; 2000 Jan; 25(1):33-40. PubMed ID: 10634528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capromab Pendetide imaging of prostate cancer.
    Haseman MK; Rosenthal SA; Polascik TJ
    Cancer Biother Radiopharm; 2000 Apr; 15(2):131-40. PubMed ID: 10803318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indium-111 capromab pendetide (ProstaScint) imaging to detect recurrent and metastatic prostate cancer.
    Petronis JD; Regan F; Lin K
    Clin Nucl Med; 1998 Oct; 23(10):672-7. PubMed ID: 9790041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients.
    Elgamal AA; Troychak MJ; Murphy GP
    Prostate; 1998 Dec; 37(4):261-9. PubMed ID: 9831223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy.
    Raj GV; Partin AW; Polascik TJ
    Cancer; 2002 Feb; 94(4):987-96. PubMed ID: 11920467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group.
    Kahn D; Williams RD; Manyak MJ; Haseman MK; Seldin DW; Libertino JA; Maguire RT
    J Urol; 1998 Jun; 159(6):2041-6; discussion 2046-7. PubMed ID: 9598514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancer.
    Ellis RJ; Kaminsky DA; Zhou EH; Fu P; Chen WD; Brelin A; Faulhaber PF; Bodner D
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):29-34. PubMed ID: 20961696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedure for unmasking localization information from ProstaScint scans for prostate radiation therapy treatment planning.
    DeWyngaert JK; Noz ME; Ellerin B; Kramer EL; Maguire GQ; Zeleznik MP
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):654-62. PubMed ID: 15380603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of radioimmunoscintigraphy with indium-111-labeled CYT-356 (ProstaScint) scan for evaluation of patients for salvage brachytherapy.
    Fang DX; Stock RG; Stone NN; Krynyckyi BR; Kim CK; Machac J
    Tech Urol; 2000 Jun; 6(2):146-50. PubMed ID: 10798816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.
    Rosenthal SA; Haseman MK; Polascik TJ
    Tech Urol; 2001 Mar; 7(1):27-37. PubMed ID: 11272670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy.
    Murphy GP; Elgamal AA; Troychak MJ; Kenny GM
    Prostate; 2000 Mar; 42(4):315-7. PubMed ID: 10679761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of 111indium-capromab pendetide imaging for assessing biochemical failure after radical prostatectomy.
    Wilkinson S; Chodak G
    J Urol; 2004 Jul; 172(1):133-6. PubMed ID: 15201753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer and prostate bed SPECT imaging with ProstaScint: semiquantitative correlation with prostatic biopsy results.
    Sodee DB; Ellis RJ; Samuels MA; Spirnak JP; Poole WF; Riester C; Martanovic DM; Stonecipher R; Bellon EM
    Prostate; 1998 Nov; 37(3):140-8. PubMed ID: 9792131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer.
    Nagda SN; Mohideen N; Lo SS; Khan U; Dillehay G; Wagner R; Campbell S; Flanigan R
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):834-40. PubMed ID: 17293236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation.
    Haseman MK; Reed NL; Rosenthal SA
    Clin Nucl Med; 1996 Sep; 21(9):704-13. PubMed ID: 8879871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.
    Polascik TJ; Manyak MJ; Haseman MK; Gurganus RT; Rogers B; Maguire RT; Partin AW
    Cancer; 1999 Apr; 85(7):1586-92. PubMed ID: 10193950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indium-111 capromab pendetide (ProstaScint) images before and after salvage radiation therapy.
    Welsh JS; Yanez MH; Chin BB; Howard SP
    Clin Nucl Med; 1999 Dec; 24(12):983. PubMed ID: 10595485
    [No Abstract]   [Full Text] [Related]  

  • 18. Dual-isotope protocol for indium-111 capromab pendetide monoclonal antibody imaging.
    Kelty NL; Holder LE; Khan SH
    J Nucl Med Technol; 1998 Sep; 26(3):174-7. PubMed ID: 9755436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure.
    Ellis RJ; Zhou EH; Fu P; Kaminsky DA; Sodee DB; Faulhaber PF; Bodner D; Resnick MI
    J Urol; 2008 May; 179(5):1768-73; discussion 1773-4. PubMed ID: 18343445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary imaging results using In-111 labeled CYT-356 (Prostascint) in the detection of recurrent prostate cancer.
    Sodee DB; Conant R; Chalfant M; Miron S; Klein E; Bahnson R; Spirnak JP; Carlin B; Bellon EM; Rogers B
    Clin Nucl Med; 1996 Oct; 21(10):759-67. PubMed ID: 8896922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.